Global Adefovir Dipivoxil API 麻豆原创 Growth 2025-2031

Publication ID:

LPI06261634

Publication Date:

June 12, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Adefovir Dipivoxil API market size is predicted to grow from US$ 42.3 million in 2025 to US$ 61.3 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Adefovir dipivoxil is a prodrug of adefovir. Adefovir is a non-cyclic nucleotide analog of adenosine monophosphate that is phosphorylated by cellular kinases to produce the active metabolite, adefovir diphosphate. Adefovir diphosphate inhibits HBV DNA polymerase (reverse transcriptase) by competing with the natural substrate deoxyadenosine triphosphate and causing DNA chain termination following its incorporation into viral DNA. It is indicated for the treatment of adult patients with chronic hepatitis B who have evidence of active viral replication and persistent elevations in serum aminotransferases (ALT or AST) or evidence of active disease on histology; this is based on histologic, virologic, biochemical, and serologic responses in adult patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and in adult patients with clinical evidence of lamivudine-resistant hepatitis B virus with compensated or decompensated liver function.
United States market for Adefovir Dipivoxil API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Adefovir Dipivoxil API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Adefovir Dipivoxil API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Adefovir Dipivoxil API players cover Chetou Pharmaceuticals, Guangdong Jinghao Biopharmaceuticals, Jiangsu Tasly Diyi Pharmaceuticals, Shandong Chenlong Pharmaceuticals, Sihauli Chemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淎defovir Dipivoxil API Industry Forecast鈥� looks at past sales and reviews total world Adefovir Dipivoxil API sales in 2024, providing a comprehensive analysis by region and market sector of projected Adefovir Dipivoxil API sales for 2025 through 2031. With Adefovir Dipivoxil API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adefovir Dipivoxil API industry.
This Insight Report provides a comprehensive analysis of the global Adefovir Dipivoxil API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adefovir Dipivoxil API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Adefovir Dipivoxil API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adefovir Dipivoxil API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adefovir Dipivoxil API.
This report presents a comprehensive overview, market shares, and growth opportunities of Adefovir Dipivoxil API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity 鈮� 99%
Purity 鈮� 98%
Segmentation by Application:
Pharmaceuticals
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Chetou Pharmaceuticals
Guangdong Jinghao Biopharmaceuticals
Jiangsu Tasly Diyi Pharmaceuticals
Shandong Chenlong Pharmaceuticals
Sihauli Chemicals
Manus Aktteva Biopharma
Inopha
Hunan Fangsheng Pharmaceutical
GSK
Key Questions Addressed in this Report
What is the 10-year outlook for the global Adefovir Dipivoxil API market?
What factors are driving Adefovir Dipivoxil API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Adefovir Dipivoxil API market opportunities vary by end market size?
How does Adefovir Dipivoxil API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Adefovir Dipivoxil API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Adefovir Dipivoxil API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Adefovir Dipivoxil API by Country/Region, 2020, 2024 & 2031
2.2 Adefovir Dipivoxil API Segment by Type
2.2.1 Purity 鈮� 99%
2.2.2 Purity 鈮� 98%
2.3 Adefovir Dipivoxil API Sales by Type
2.3.1 Global Adefovir Dipivoxil API Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Adefovir Dipivoxil API Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Adefovir Dipivoxil API Sale Price by Type (2020-2025)
2.4 Adefovir Dipivoxil API Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.5 Adefovir Dipivoxil API Sales by Application
2.5.1 Global Adefovir Dipivoxil API Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Adefovir Dipivoxil API Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Adefovir Dipivoxil API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Adefovir Dipivoxil API Breakdown Data by Company
3.1.1 Global Adefovir Dipivoxil API Annual Sales by Company (2020-2025)
3.1.2 Global Adefovir Dipivoxil API Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Adefovir Dipivoxil API Annual Revenue by Company (2020-2025)
3.2.1 Global Adefovir Dipivoxil API Revenue by Company (2020-2025)
3.2.2 Global Adefovir Dipivoxil API Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Adefovir Dipivoxil API Sale Price by Company
3.4 Key Manufacturers Adefovir Dipivoxil API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Adefovir Dipivoxil API Product Location Distribution
3.4.2 Players Adefovir Dipivoxil API Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Adefovir Dipivoxil API by Geographic Region
4.1 World Historic Adefovir Dipivoxil API 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Adefovir Dipivoxil API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Adefovir Dipivoxil API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Adefovir Dipivoxil API 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Adefovir Dipivoxil API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Adefovir Dipivoxil API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Adefovir Dipivoxil API Sales Growth
4.4 APAC Adefovir Dipivoxil API Sales Growth
4.5 Europe Adefovir Dipivoxil API Sales Growth
4.6 Middle East & Africa Adefovir Dipivoxil API Sales Growth
5 Americas
5.1 Americas Adefovir Dipivoxil API Sales by Country
5.1.1 Americas Adefovir Dipivoxil API Sales by Country (2020-2025)
5.1.2 Americas Adefovir Dipivoxil API Revenue by Country (2020-2025)
5.2 Americas Adefovir Dipivoxil API Sales by Type (2020-2025)
5.3 Americas Adefovir Dipivoxil API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adefovir Dipivoxil API Sales by Region
6.1.1 APAC Adefovir Dipivoxil API Sales by Region (2020-2025)
6.1.2 APAC Adefovir Dipivoxil API Revenue by Region (2020-2025)
6.2 APAC Adefovir Dipivoxil API Sales by Type (2020-2025)
6.3 APAC Adefovir Dipivoxil API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Adefovir Dipivoxil API by Country
7.1.1 Europe Adefovir Dipivoxil API Sales by Country (2020-2025)
7.1.2 Europe Adefovir Dipivoxil API Revenue by Country (2020-2025)
7.2 Europe Adefovir Dipivoxil API Sales by Type (2020-2025)
7.3 Europe Adefovir Dipivoxil API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adefovir Dipivoxil API by Country
8.1.1 Middle East & Africa Adefovir Dipivoxil API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Adefovir Dipivoxil API Revenue by Country (2020-2025)
8.2 Middle East & Africa Adefovir Dipivoxil API Sales by Type (2020-2025)
8.3 Middle East & Africa Adefovir Dipivoxil API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Adefovir Dipivoxil API
10.3 Manufacturing Process Analysis of Adefovir Dipivoxil API
10.4 Industry Chain Structure of Adefovir Dipivoxil API
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Adefovir Dipivoxil API Distributors
11.3 Adefovir Dipivoxil API Customer
12 World Forecast Review for Adefovir Dipivoxil API by Geographic Region
12.1 Global Adefovir Dipivoxil API 麻豆原创 Size Forecast by Region
12.1.1 Global Adefovir Dipivoxil API Forecast by Region (2026-2031)
12.1.2 Global Adefovir Dipivoxil API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Adefovir Dipivoxil API Forecast by Type (2026-2031)
12.7 Global Adefovir Dipivoxil API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Chetou Pharmaceuticals
13.1.1 Chetou Pharmaceuticals Company Information
13.1.2 Chetou Pharmaceuticals Adefovir Dipivoxil API Product Portfolios and Specifications
13.1.3 Chetou Pharmaceuticals Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Chetou Pharmaceuticals Main Business Overview
13.1.5 Chetou Pharmaceuticals Latest Developments
13.2 Guangdong Jinghao Biopharmaceuticals
13.2.1 Guangdong Jinghao Biopharmaceuticals Company Information
13.2.2 Guangdong Jinghao Biopharmaceuticals Adefovir Dipivoxil API Product Portfolios and Specifications
13.2.3 Guangdong Jinghao Biopharmaceuticals Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Guangdong Jinghao Biopharmaceuticals Main Business Overview
13.2.5 Guangdong Jinghao Biopharmaceuticals Latest Developments
13.3 Jiangsu Tasly Diyi Pharmaceuticals
13.3.1 Jiangsu Tasly Diyi Pharmaceuticals Company Information
13.3.2 Jiangsu Tasly Diyi Pharmaceuticals Adefovir Dipivoxil API Product Portfolios and Specifications
13.3.3 Jiangsu Tasly Diyi Pharmaceuticals Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jiangsu Tasly Diyi Pharmaceuticals Main Business Overview
13.3.5 Jiangsu Tasly Diyi Pharmaceuticals Latest Developments
13.4 Shandong Chenlong Pharmaceuticals
13.4.1 Shandong Chenlong Pharmaceuticals Company Information
13.4.2 Shandong Chenlong Pharmaceuticals Adefovir Dipivoxil API Product Portfolios and Specifications
13.4.3 Shandong Chenlong Pharmaceuticals Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Shandong Chenlong Pharmaceuticals Main Business Overview
13.4.5 Shandong Chenlong Pharmaceuticals Latest Developments
13.5 Sihauli Chemicals
13.5.1 Sihauli Chemicals Company Information
13.5.2 Sihauli Chemicals Adefovir Dipivoxil API Product Portfolios and Specifications
13.5.3 Sihauli Chemicals Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sihauli Chemicals Main Business Overview
13.5.5 Sihauli Chemicals Latest Developments
13.6 Manus Aktteva Biopharma
13.6.1 Manus Aktteva Biopharma Company Information
13.6.2 Manus Aktteva Biopharma Adefovir Dipivoxil API Product Portfolios and Specifications
13.6.3 Manus Aktteva Biopharma Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Manus Aktteva Biopharma Main Business Overview
13.6.5 Manus Aktteva Biopharma Latest Developments
13.7 Inopha
13.7.1 Inopha Company Information
13.7.2 Inopha Adefovir Dipivoxil API Product Portfolios and Specifications
13.7.3 Inopha Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Inopha Main Business Overview
13.7.5 Inopha Latest Developments
13.8 Hunan Fangsheng Pharmaceutical
13.8.1 Hunan Fangsheng Pharmaceutical Company Information
13.8.2 Hunan Fangsheng Pharmaceutical Adefovir Dipivoxil API Product Portfolios and Specifications
13.8.3 Hunan Fangsheng Pharmaceutical Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hunan Fangsheng Pharmaceutical Main Business Overview
13.8.5 Hunan Fangsheng Pharmaceutical Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Adefovir Dipivoxil API Product Portfolios and Specifications
13.9.3 GSK Adefovir Dipivoxil API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.